Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Renaud de Beaurepaire

Biographic Data

ID6267996
NAMERenaud de Beaurepaire
GIVEN NAMESRenaud
FAMILY NAMEde Beaurepaire
SIGNATUREDE BEAUREPAIRE R
AFFILIATIONSHôpital Paul-Brousse
ORCID0000-0001-8821-9637
VERIFIEDYes
TOTAL WORKS4
TOTAL CITATIONS0
WORKS AS AUTHOR4
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2006
LATEST PUBLICATION YEAR2022
H-INDEX0
  • Baclofen in alcohol use disorder

    Open Access•Renaud de Beaurepaire, Benjamin Rolland•ARTICLE•Frontiers in Psychiatry•2022

    Alcohol use disorder (AUD) is a devastating illness for which effective treatments are lacking. Studies over the last two decades have shown that baclofen, a GABA-B agonist, could be a promising treatment for AUD. However, the efficacy of baclofen is still controversial, and studies have shown that it may be associated with an excess of hospitalizations and deaths. In March 2014, the French Health Safety Agency granted a "Temporary Recommendation…

  • The Use of Very High-Doses of Baclofen for the Treatment of Alcohol-Dependence

    Open Access•Renaud de Beaurepaire•ARTICLE•Frontiers in Psychiatry•2014

    Baclofen, particularly high-dose baclofen, has recently emerged as a treatment of major interest for alcohol-dependence. However, baclofen has many potentially dangerous side effects, and the maximal dose of baclofen that may be used is a matter of discussion. Here, the author analyses the medical charts of the last 100 patients seen in his clinic, 17 of whom have been taking a very high dose of baclofen, which is to say, more than 300 mg/day. Th…

  • Suppression of Alcohol Dependence Using Baclofen

    Open Access•Renaud de Beaurepaire•ARTICLE•Frontiers in Psychiatry•2012

    Baclofen produces an effortless decrease or suppression of alcohol craving when it is prescribed with no superior limit of dose. Potential limitations in the effectiveness of baclofen include the coexistence of a mental disorder, the concomitant use of other psychotropic drugs, a lack of real motivation in patients to stop drinking, and the impossibility to reach the optimal dose of baclofen because of unbearable side-effects (sometimes possibly …

  • Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration

    Open Access•Julie Minet-Ringuet, Patrick C Even et al.•ARTICLE•Appetite•2006•References: 44

No prominent works on this page.

  • Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration

    Open Access•Julie Minet-Ringuet, Patrick C Even et al.•ARTICLE•Appetite•2006•References: 44

  • Suppression of Alcohol Dependence Using Baclofen

    Open Access•Renaud de Beaurepaire•ARTICLE•Frontiers in Psychiatry•2012

    Baclofen produces an effortless decrease or suppression of alcohol craving when it is prescribed with no superior limit of dose. Potential limitations in the effectiveness of baclofen include the coexistence of a mental disorder, the concomitant use of other psychotropic drugs, a lack of real motivation in patients to stop drinking, and the impossibility to reach the optimal dose of baclofen because of unbearable side-effects (sometimes possibly …

  • The Use of Very High-Doses of Baclofen for the Treatment of Alcohol-Dependence

    Open Access•Renaud de Beaurepaire•ARTICLE•Frontiers in Psychiatry•2014

    Baclofen, particularly high-dose baclofen, has recently emerged as a treatment of major interest for alcohol-dependence. However, baclofen has many potentially dangerous side effects, and the maximal dose of baclofen that may be used is a matter of discussion. Here, the author analyses the medical charts of the last 100 patients seen in his clinic, 17 of whom have been taking a very high dose of baclofen, which is to say, more than 300 mg/day. Th…

  • Baclofen in alcohol use disorder

    Open Access•Renaud de Beaurepaire, Benjamin Rolland•ARTICLE•Frontiers in Psychiatry•2022

    Alcohol use disorder (AUD) is a devastating illness for which effective treatments are lacking. Studies over the last two decades have shown that baclofen, a GABA-B agonist, could be a promising treatment for AUD. However, the efficacy of baclofen is still controversial, and studies have shown that it may be associated with an excess of hospitalizations and deaths. In March 2014, the French Health Safety Agency granted a "Temporary Recommendation…

Internal Medicine (4 works) · Medicine (4 works) · Alcohol (3 works) · Baclofen (3 works) · Botulinum Toxin and Related Neurological Disorders (3 works) · Psychiatry (3 works) · Agonist (2 works) · Alcohol Consumption and Health Effects (2 works) · Alcohol dependence (2 works) · Pharmacology (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae